Vectorized antibodies hold promise to overcome many of these limitations and provide a great opportunity for DNA and RNA technology companies to enter larger markets compared with the rare disease ...
Vectorized Inc., a new data management startup, today disclosed that it has raised $15.5 million across two funding rounds from Lightspeed Venture Partners and Alphabet Inc.’s GV fund. The startup’s ...
SAN FRANCISCO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Vectorized, Inc., the Intelligent Data API company, today announced the general availability of Redpanda, the Intelligent Data API Platform. Vectorized ...
A year after AbbVie and Voyager Therapeutics teamed up on Alzheimer’s disease, they are expanding their partnership to include Parkinson’s disease and other diseases in which misfolded alpha-synuclein ...
ORLANDO, Fla.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, announced today that ...
Not all drug targets are created equal. For those that result in a tissue-specific gain-of-function, the strategy can be not-so-straightforward. That’s exactly what’s going on in some forms of ...
A randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. This is an ASCO Meeting Abstract from the 2012 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results